Stem cells-based therapies for dry type of age related macular degeneration:current status and future prospects

Yalong Dang,Yongsheng Xu,Chun Zhang
DOI: https://doi.org/10.3877/cma.j.issn.2095-1221.2014.02.008
2014-01-01
Abstract:Age related macular degeneration (AMD) is one of the leading causes of irreversible visual impairment in the developed and developing countries. The management of neovascular AMD (wet AMD) showed remarkable progression in the past decade. However, nonneovascular AMD (dry AMD) characterized by geographic macular atrophy still cannot be cured. Recently, it is demonstrated that retinal pigment cells may be generated from the stem cells by defined factors or cell co-culturing. Studies also showed cell transplantation may restore visual function in vivo. Moreover, several clinical trails approved by the FDA have showed the promising prospect in stem cells-based therapies in dry AMD. This review will focus on recent advances in stem cell-based RPE differentiation, cell transplantation, clinical trials and the obstacles that must be overcomed for stem cell therapy in dry AMD.
What problem does this paper attempt to address?